Medicinal Products

Nebilet Plus 5 mg/25 mg filmom obložene tablete

Name Nebilet Plus 5 mg/25 mg filmom obložene tablete
Marketing Authorisation Number HR-H-340964911
Active Substance nebivololklorid
hidroklorotiazid
Composition jedna tableta Nebileta Plus 5 mg / 25 mg sadrži 5 mg nebivolola (u obliku nebivololklorida: 2,5 mg SRRR-nebivolola ili d-nebivolola i 2,5 mg RSSS-nebivolola ili l-nebivolola) i 25 mg hidroklorotiazida
Pharmaceutical Form filmom obložena tableta
Manufacturer Berlin-Chemie AG, Berlin, Njemačka
Menarini-Von Heyden GmbH, Dresden, Njemačka
A. Menarini Manufacturing Logistics And Services S.r.l., Firenca, Italija
Marketing Authorisation Holder Berlin-Chemie Menarini Hrvatska d.o.o., Horvatova 80a, Zagreb, Hrvatska
Marketing Authorisation Date 31.08.2017
MA Period of Validity unlimited
Classification Number UP/I-530-09/16-02/343
Registration Number 381-12-01/14-17-05
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code C07BB12
Marketing status stavljeno u promet
Shortage status nema nestašice
SmPC download
PL download

Packaging

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od nemelanomskog raka kože povezanog s primjenom hidroklorotiazida 17.10.2018 Alkaloid, Belupo, Berlin-Chemie Menarini, Boehringer Ingelheim International, Farmal, Genericon, Pharma, Jadran Galenski laboratorij, Krka - farma, Merck, Merck Sharp & Dohme, Novartis, PharmaSwiss, Pliva, Sandoz, sanofi-aventis i Stada
Back